Learn More
Medchemexpress LLC THR-β agonist 2 | 2440027-77-8 | 99.3% | C18H8Cl2N6O4 | 1 ML

Supplier: Medchemexpress LLC HY14361310MM/1ML
THR-β agonist 2 is a potent agonist of THR-β with potential for research into metabolic diseases. This includes conditions such as obesity, hyperlipidemia, hypercholesterolemia, and diabetes. It also shows promise for steatosis, non-alcoholic steatohepatitis (NASH), atherosclerosis, and other related conditions and diseases. This compound is derived from patent WO2021121210A1, specifically compound 3.
- Potent THR-β agonist.
- Potential for research in metabolic diseases.
- Useful for studying obesity, hyperlipidemia, and hypercholesterolemia.
- Applicable in research related to diabetes.
- Shows promise for steatosis and non-alcoholic steatohepatitis (NASH) studies.
- Relevant for atherosclerosis research.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.